Bioerodible metallic ENDOPROSTHESES

1. An implantable endoprosthesis comprising:

a bioerodible body comprising a first bioerodible metallic material, the bioerodible body having a thickness of between about 0.5 mm and about 5.0 mm; and

a plurality of discrete, spaced apart bioerodible deposits comprising a second bioerodible metallic material different from the first bioerodible metallic material, said deposits of the second bioerodible metallic material overlying the first bioerodible metallic material at a plurality of regions, each deposit having a thickness of between about 0.01 μm to about 5 μm; each region having a surface area of not more than about 25 μm 2 , wherein the second bioerodible metallic material forms a continuous interface with the first bioerodible metallic material over the entirety of each region;

wherein a longitudinal spacing between immediately adjacent deposits is between about 1.0 μm and about 35 μm;

wherein a transverse spacing between immediately adjacent deposits is between about 1.0 μm and about 35 μm, measured along an outer surface of the bioerodible body from which the deposits extend;

wherein, when implanted within a body lumen, the bioerodible body and each deposit together define a galvanic couple that enhances a rate of erosion of the discrete, spaced apart bioerodible deposits, and wherein a standard cell potential for the galvanic couple is at least +1.0 V;

wherein erosion of the discrete, spaced apart bioerodible deposits creates crevices in the bioerodible body proximate the discrete, spaced apart bioerodible deposits, and wherein the crevices in the bioerodible body have an enhanced rate of erosion resulting in the body disintegrating into fragments having a maximum dimension of not more than 15 μm.

2. The implantable endoprosthesis of claim 1 , further comprising a coating about the endoprosthesis.

3. The implantable endoprosthesis of claim 2 , wherein the coating fills only spaces between the discrete, spaced apart deposits.

4. The implantable endoprosthesis of claim 2 , wherein the coating comprises a therapeutic agent.

5. The implantable endoprosthesis of claim 4 , wherein the therapeutic agent inhibits restenosis.

6. The implantable endoprosthesis of claim 1 , wherein each of the bioerodible metallic materials is selected from the group consisting of iron, magnesium, zinc, aluminum, calcium, and alloys thereof.

7. The implantable endoprosthesis of claim 1 , wherein the implantable endoprosthesis is in the form of a stent.

8. The implantable endoprosthesis of claim 1 , wherein the fragments have a maximum dimension of not more than 5 μm.